Education
About Us
Working with TipRanks
Follow Us
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
4577 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥1,992.00 - ¥2,573.00
Previous CloseN/A
Volume21.10K
Average Volume (3M)32.97K
Market Cap
¥32.70B
Enterprise Value¥40.21B
Total Cash (Recent Filing)¥2.10B
Total Debt (Recent Filing)¥7.38B
Price to Earnings (P/E)12.4
Beta0.37
Next Earnings
Oct 09, 2025Next Dividend Ex-Date
May 29, 2025Dividend Yield3.14%
Share Statistics
EPS (TTM)20.34
Shares Outstanding15,348,440
10 Day Avg. Volume33,290
30 Day Avg. Volume32,970
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Daito Pharmaceutical Co., Ltd. News
PremiumCompany Announcements
Daito Pharmaceutical Revises Earnings Forecast Amid Cost Challenges
PremiumCompany Announcements
Daito Pharmaceutical Reports Increased Sales but Declining Profits
PremiumCompany Announcements
Daito Pharmaceutical Announces Share Repurchase
PremiumCompany Announcements
Daito Pharmaceutical Announces Share Repurchase
PremiumCompany Announcements
Daito Pharmaceutical Announces Corrections to Financial Results
PremiumCompany Announcements
Daito Pharmaceutical Announces Strategic Share Buyback
PremiumCompany Announcements
Daito Pharmaceutical Corrects First Half Fiscal 2025 Financial Presentation
PremiumCompany Announcements
Daito Pharmaceutical Announces Stock Split to Boost Liquidity---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
8.78%
Mutual Funds
― Other Institutional Investors
88.71% Public Companies and
Individual Investors
4577 FAQ
What was Daito Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Daito Pharmaceutical Co., Ltd. lowest stock price was ¥1992.00 and its highest was ¥2573.00 in the past 12 months.
What is Daito Pharmaceutical Co., Ltd.’s market cap?
Daito Pharmaceutical Co., Ltd.’s market cap is ¥32.70B.
When is Daito Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Daito Pharmaceutical Co., Ltd.’s upcoming earnings report date is Oct 09, 2025 which is in 165 days.
How were Daito Pharmaceutical Co., Ltd.’s earnings last quarter?
Daito Pharmaceutical Co., Ltd. released its earnings results on Apr 14, 2025. The company reported ¥20.34 earnings per share for the quarter, beating the consensus estimate of N/A by ¥20.34.
Is Daito Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Daito Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Daito Pharmaceutical Co., Ltd. pay dividends?
Daito Pharmaceutical Co., Ltd. pays a Annually dividend of ¥35 which represents an annual dividend yield of 3.14%. See more information on Daito Pharmaceutical Co., Ltd. dividends here
What is Daito Pharmaceutical Co., Ltd.’s EPS estimate?
Daito Pharmaceutical Co., Ltd.’s EPS estimate is 0.
How many shares outstanding does Daito Pharmaceutical Co., Ltd. have?
Daito Pharmaceutical Co., Ltd. has 15,348,440 shares outstanding.
What happened to Daito Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Daito Pharmaceutical Co., Ltd. reported an EPS of ¥20.34 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.314%.
Which hedge fund is a major shareholder of Daito Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4577
---
Company Description
Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
---
Technical Analysis
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Sumitomo Dainippon Pharma Co
―
ONO Pharmaceutical Co
―
Shionogi & Co
―
---